Liver Cancer
Liver cirrhosis prognosis determined after first hepatic encephalopathy episode
Published in Hepatitis Weekly, October 25th, 2004
"This study was carried out in Japanese patients to clarify the state of liver cirrhosis complicated by hepatic encephalopathy with and without hepatocellular carcinoma and its prognosis.
"The subjects were 100 patients with liver cirrhosis complicated by hepatic encephalopathy. Clinical data were investigated, and prognostic factors were extracted using Cox's proportional hazard model," researchers in Japan report.
"The cumulative survival rate after the first episode of hepatic encephalopathy was 59.1% after 1 year, 48.3% after 2 years,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-10-25)
More Articles from Hepatitis Weekly
- Adverse Drug Effects
Pegylated interferon may cause vision disorders in chronic hepatitis C patients - Bioreactors
Escherichia coli produces purified hepatitis C virus NS5A protein - Chronic Hepatitis C
Hepatitis C virus infection does not stimulate hepatic interferon production - Gastroenterology
Liver enzymes monitor post-surgical liver function in those with HCV antibody - Hepatitis B Virus Therapy
Small interfering RNA stifles the production of hepatitis B virus - Cancer Research
Study questions link between SV40 and pleural mesothelioma - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
